Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.

Abstract

T-614, a new slow-acting drug, is effective in treatment of rheumatoid arthritis and is well tolerated.